Assistance publique Hopitaux de Marseille - Hopital Nord
Marseille, 13015, France
Location status: Recruiting
Location contact
Alex Fourdrain, MD, PhD
CONTACT
Alex Fourdrain, Md, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06577844
Uni-centric, randomized, open-label, prospective interventional-comparative study, with a control arm (patients receiving standard preoperative information) and an experimental arm (patients receiving standard preoperative information and having access to a dematerialized educational video support).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Marseille, 13015, France
Location status: Recruiting
Alex Fourdrain, MD, PhD
CONTACT
Alex Fourdrain, Md, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for therapeutic purposes (in the case of proven tumor histology) or for diagnostic and therapeutic purposes (in the absence of proven histology, but strong suspicion, after validation by RCP),
Exclusion criteria
video support provided to the patient before surgery
Time frame: 10 days
self-measurement using the HAD Scale
Time frame: 90 days
based on HAD scale
Time frame: 90 days
PCL-5 scale
Time frame: 90 days
European Organisation for Research and Treatment of Cancer core health- related quality of life questionnaire (QLQ-C30).
Time frame: 90 days
score CCI
Time frame: 90 days
accounting for in-hospital consumption of analgesics
Contact information is provided by the study sponsor or research team.
Assistance Publique Hopitaux De Marseille
Other
Acronym: SUVIDEM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06636721
Anxiety Disorders, Behavior
Durham, North Carolina, United States
View Trial DetailsNCT06199050
Anxiety, Anxiety Disorders
Maastricht, Netherlands
View Trial DetailsNCT06008574
Anxiety Disorders, Lung Cancer
Basking Ridge, New Jersey, United States
View Trial DetailsNCT00984321
Anxiety Disorders, Behavior
New York, United States
View Trial Details